ESR1 in myocardial infarction

Area of Science:

• Endocrinology
• Cardiovascular Biology
• Genetics

Background:

• Estrogens, primarily 17β-estradiol (E2), contribute to women's longer lifespan.
• E2 is produced by ovaries and extra-ovarian tissues, acting through nuclear receptors ERα and ERβ.
• E2 mediates genomic and rapid non-genomic cellular effects.

Purpose of the Study:

• To explore the cardioprotective role of estrogen receptor alpha (ERα).
• To investigate the mechanisms of E2 action in cardiovascular health.
• To examine the association between ESR1 gene variations and cardiovascular disease.

Main Methods:

• Review of existing literature on estrogen, ERα, and cardiovascular function.
• Analysis of animal models demonstrating ERα's effects on cardiac ischemia.
• Examination of human genetic studies on ESR1 polymorphisms and cardiovascular disease.

Main Results:

• ERα activation in animal models reduces cardiac infarct size, apoptosis, inflammation, and oxidative stress.
• ERα activation promotes vasodilation and neovascularization in cardiac ischemia models.
• Evidence linking ESR1 mutations to cardiovascular disease and the role of ESR1 polymorphisms remains inconclusive in humans.

Conclusions:

• ERα exhibits significant cardioprotective effects in preclinical models.
• The precise role and clinical implications of ERα in human cardiovascular health require further elucidation.
• Genetic variations in ESR1 may be associated with cardiovascular disease risk, but require more robust evidence.